T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study
Clinical and Translational Allergy · 2025-02 · 15 (2)
DOI: 10.1002/clt2.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 29.01.2025. Verfasst von Konstantinos Porpodis und 34 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Department, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca S.A. Greece.
Abstract (Originalsprache)
Background
Data on type 2 (T2)‐low severe asthma (SA) frequency is scarce, resulting in an undefined unmet therapeutic need in this patient population. Our objective was to assess the frequency and characterize the profile and burden of T2‐low SA in Greece.
Methods
PHOLLOW was a cross‐sectional study of adult SA patients. Based on a novel proposed classification system, patients were classified as T2‐low if blood eosinophil count (BEC; cells/μL) was
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonary Department, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece.
- Respiratory Department, Navy Hospital of Athens, Athens, Greece.
- Respiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.
- Department of Respiratory Medicine, Medical School, University of Patras, Patras, Greece.
- 2nd Department of Dermatology and Venereology, Allergy Unit, Medical School, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece.
ORCID-Profile: George N Konstantinou, Petros Bakakos
Förderung
- AstraZeneca S.A. Greece
Zitieren
APA
Porpodis, K., Zias, N., Kostikas, K., Tzouvelekis, A., Makris, M., Konstantinou, G. N., Zervas, E., Loukides, S., Steiropoulos, P., Katsoulis, K., Palamidas, A., Syrigou, A., Gangadi, M., Christopoulos, A., Papapetrou, D., Psarros, F., Gourgoulianis, K., Tzortzaki, E., Vittorakis, S. K., …, & Bakakos, P. (2025). T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study. Clinical and Translational Allergy, 15(2). https://doi.org/10.1002/clt2.70035
Vancouver
Porpodis K, Zias N, Kostikas K, Tzouvelekis A, Makris M, Konstantinou GN, et al. T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study. Clinical and Translational Allergy. 2025;15(2). doi:10.1002/clt2.70035
BibTeX
@article{Porpodis2025,
author = {Porpodis, Konstantinos and Zias, Nikolaos and Kostikas, Konstantinos and Tzouvelekis, Argyris and Makris, Michael and Konstantinou, George N and Zervas, Eleftherios and Loukides, Stelios and Steiropoulos, Paschalis and Katsoulis, Konstantinos and Palamidas, Anastasios and Syrigou, Aikaterini and Gangadi, Maria and Christopoulos, Antonios and Papapetrou, Dimosthenis and Psarros, Fotios and Gourgoulianis, Konstantinos and Tzortzaki, Eleni and Vittorakis, Stylianos K and Paraskevopoulos, Ioannis and Papanikolaou, Ilias and Krommidas, Georgios and Latsios, Dimitrios and Tzanakis, Nikolaos and Markatos, Miltiadis and Damianaki, Angeliki and Manikas, Argyrios and Chatzipetrou, Alexia and Vourdas, Dimitrios and Tsiouprou, Ioanna and Papista, Christina and Bartsakoulia, Marina and Mathioudakis, Nikolas and Galanakis, Petros and Bakakos, Petros},
title = {T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study},
journal = {Clinical and Translational Allergy},
year = {2025},
volume = {15},
number = {2},
doi = {10.1002/clt2.70035}
}
EUVIMED